INTELLIGENT BIO SOLUTIONS INC.
Financial highlights
| Metric | FY 06/30/25 | FY 06/30/24 | FY 06/30/23 | FY 06/30/22 | FY 06/30/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $3.1M | $3.1M | $1.3M | $437,146 | $2.0M |
| Cost of revenue | $1.8M | $1.7M | $930,204 | — | — |
| Gross profit | $1.2M | $1.4M | $326,668 | — | — |
| Operating expenses | $12.7M | $12.1M | $13.7M | $8.8M | $7.6M |
| Operating income | -$10.6M | -$10.3M | -$12.6M | -$8.3M | -$5.6M |
| Interest expense | $60,890 | $167,140 | — | — | — |
| Pretax income | — | — | — | — | -$7.1M |
| Net income | -$10.6M | -$10.2M | -$10.6M | -$8.3M | -$7.0M |
| Balance Sheet | |||||
| Cash and equivalents | $1.0M | $6.3M | $1.5M | $8.2M | $12.6M |
| Current assets | $4.1M | $8.5M | $3.9M | $10.9M | $18.2M |
| Total assets | $8.2M | $13.8M | $10.4M | $12.4M | $21.9M |
| Current liabilities | $5.4M | $5.5M | $5.9M | $4.7M | $3.7M |
| Total liabilities | $5.4M | $5.6M | $6.7M | $5.8M | $6.9M |
| Stockholders' equity | $3.0M | $8.3M | $3.8M | $6.6M | $15.1M |
| Cash Flow Statement | |||||
| Cash from operations | -$9.7M | -$9.6M | -$7.4M | -$3.4M | -$11.3M |
| Depreciation and amortization | $970,117 | $974,355 | $814,481 | $0 | — |
| Stock-based compensation | $238,045 | $230,496 | $260,000 | — | — |
| Capital expenditure | $231,838 | $221,426 | — | — | — |
| Free cash flow | -$9.9M | -$9.8M | — | — | — |
| Impairments | — | — | $4.2M | — | — |
Shares outstanding 2.4M · Free float 40.0%
Annual filing data through FY ended June 30, 2025; float as of July 15, 2026.